Related Experiment Video
Updated: Jan 17, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Curcumin suppresses colorectal cancer by inhibiting TRIM2 and mTOR signaling
Hang Yu1, Haikuo Wu1, Qianhui Zhao1
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Abstract:
Curcumin, a natural polyphenol, exhibits potent anti-cancer activities, but its underlying molecular mechanisms in colorectal cancer (CRC) are not fully elucidated. Here, we investigated t whether curcumin suppresses CRC by targeting tripartite motif-containing protein 2 (TRIM2) and its downstream the Mammalian Target of Rapamycin (mTOR) signaling pathway. We initially performed a whole-genome expression profile chip to examine gene alterations following curcumin administration. Our results demonstrate that curcumin effectively decreased the expression of TRIM2 in CRC cells. Furthermore, PCR and immunohistochemical (IHC) staining of tumour samples confirmed the elevated expression of TRIM2 in CRC cells and CRC tumour samples. Additionally, we assessed the effect of TRIM2 knockdown on the proliferation of CRC cells and tumour growth using cell and animal experiments. mTOR pathway activity was interrogated using phospho‑kinase arrays and immunoblotting, with pharmacologic rescue by an mTOR activator. Our findings revealed that curcumin administration and TRIM2 knockdown effectively suppressed the migration and proliferation of CRC cells and mTOR activation partially reversed these effects, Mechanistically, TRIM2 depletion dampened mTOR signaling, reducing phosphorylation of AKT (Ser473), and S6K/4EBP1 without altering total protein levels. These findings indicate curcumin inhibits CRC onset and progression by downregulating TRIM2 and suppressing mTOR pathway activity, suggesting TRIM2 may serve as a potential prognostic marker in CRC.
Insights
Curcumin, a natural compound, inhibits colorectal cancer (CRC) by reducing tripartite motif-containing protein 2 (TRIM2) and the mTOR pathway. This suggests TRIM2 as a potential prognostic marker for CRC.
Area of Science:
- Oncology
- Molecular Biology
- Natural Products Chemistry
Background:
- Colorectal cancer (CRC) remains a significant health challenge globally.
- The anti-cancer properties of curcumin, a natural polyphenol, are recognized, but its precise molecular targets in CRC require further investigation.
- Understanding the molecular mechanisms of curcumin in CRC is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate whether curcumin suppresses colorectal cancer (CRC) by targeting tripartite motif-containing protein 2 (TRIM2) and its downstream Mammalian Target of Rapamycin (mTOR) signaling pathway.
- To elucidate the molecular mechanisms underlying curcumin's anti-cancer effects in CRC.
- To evaluate the potential of TRIM2 as a prognostic marker in CRC.
Main Methods:
- Whole-genome expression profile chip analysis to identify gene alterations after curcumin administration.
- Quantitative PCR and immunohistochemical (IHC) staining to assess TRIM2 expression in CRC cells and tissues.
- Cell and animal experiments to evaluate the impact of TRIM2 knockdown on CRC cell proliferation and tumor growth.
- Phospho-kinase arrays and immunoblotting to interrogate mTOR pathway activity, with pharmacologic rescue using an mTOR activator.
Main Results:
- Curcumin significantly decreased TRIM2 expression in CRC cells.
- Elevated TRIM2 expression was confirmed in CRC cells and tumor samples.
- TRIM2 knockdown and curcumin administration suppressed CRC cell migration and proliferation.
- mTOR pathway activation was dampened by TRIM2 depletion, reducing AKT and S6K/4EBP1 phosphorylation.
- Partial reversal of curcumin's effects was observed upon mTOR pathway activation.
Conclusions:
- Curcumin inhibits colorectal cancer (CRC) onset and progression by downregulating TRIM2 and suppressing mTOR pathway activity.
- TRIM2 plays a critical role in CRC proliferation and migration via the mTOR signaling pathway.
- TRIM2 may serve as a potential prognostic marker for colorectal cancer (CRC).
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Inhibition of Cdk Activity
Cancer Prevention
Some...
Drugs that Stabilize Microtubules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

